Area of research
Oncology · Radiation
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Advanced Radiotherapy Techniques, Hepatocellular Carcinoma Treatment and Prognosis, and Cholangiocarcinoma and Gallbladder Cancer Studies.
Impact of target volume and dose concepts on the outcomes of prostate cancer patients treated with stereotactic body radiotherapy for spinal metastases − a European multicenter cohort study
Tumor control probability modeling of pulmonary metastases in oligometastatic head and neck squamous cell carcinoma treated with stereotactic body radiation therapy
Evaluating the efficacy and immunological impact of combined ICIs and SBRT in HCC: A narrative literature review.
Reply to: Quality of Chemoradiotherapy in Esophageal Adenocarcinoma Matters.
Stereotactic body radiotherapy in patients with bone oligometastases from breast cancer – results from a European multicenter cohort study
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer.
Pulmonary Stereotactic Body Radiation Therapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma: A Multicenter Retrospective Study
Recurrence Patterns of Esophageal Adenocarcinoma in the Phase III ESOPEC Trial Comparing Perioperative Chemotherapy With Preoperative Chemoradiotherapy.
Planning Benchmark Study for Stereotactic Body Radiation Therapy of Pancreas Carcinomas With Simultaneously Integrated Boost and Protection: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery
Impact of target volume and dose concepts on the outcomes of prostate cancer patients treated with stereotactic body radiotherapy for spinal metastases − a European multicenter cohort study
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Kurzversion
S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion
S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Kurzversion
Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial).
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy
Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery.
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0
Metastasis-directed stereotactic radiotherapy in patients with breast cancer: results of an international multicenter cohort study
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion
Identifying core MRI sequences for reliable automatic brain metastasis segmentation
Identifying core MRI sequences for reliable automatic brain metastasis segmentation.
The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer.
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome
Identifying core MRI sequences for reliable automatic brain metastasis segmentation
Data from The Mitochondrial Disruptor Devimistat (CPI-613) Synergizes with Genotoxic Anticancer Drugs in Colorectal Cancer Therapy in a Bim-Dependent Manner
Supplementary Data from The Mitochondrial Disruptor Devimistat (CPI-613) Synergizes with Genotoxic Anticancer Drugs in Colorectal Cancer Therapy in a Bim-Dependent Manner